Latest First Analysis news

First Analysis, a leading venture capital investor, has made a new investment in Gradient Cyber, a leading provider of managed extended detection and response (MXDR) services for mid-market organizations. First Analysis led the Series A financing, which will support Gradient Cyber’s continued growth and product development as it scales to meet increasing demand for 24/7 MXDR services.

First Analysis, a leading venture capital firm specializing in B2B technology investments, announced today the closing of its 14th fund, at $97 million in committed capital. First Analysis again committed substantial capital to its own fund, making it the largest investor in the new fund and underscoring its continued confidence in its distinctive investment approach.

Thoma Bravo, a leading software investment firm, has made a strategic growth investment in PCMI, a portfolio company of First Analysis and Equality Asset Management. PCMI is a leading provider of administration software for finance and insurance products in the automotive and consumer end markets. Thoma Bravo’s expertise in scaling technology companies will help accelerate PCMI’s global growth and support its efforts in enhancing the platform. William Blair acted as the exclusive financial advisor to PCMI.

Euna Solutions, a provider of SaaS solutions purpose-built for the public sector, has acquired First Analysis portfolio company AmpliFund, a leading grant management platform provider. This strategic move enhances Euna Solutions’ existing grant management product suite, further solidifying its commitment to delivering innovative and comprehensive tools for government agencies, nonprofits and other public sector organizations.

First Analysis acted as the exclusive financial advisor to The Benefits eXpert® (TBX®), an employee benefits technology company that offers an engagement, education and administrative platform, in its sale to Selerix, a provider of cloud-based benefits administration and communications solutions.

First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations.

Accel-KKR has acquired First Analysis portfolio company VisiQuate, a provider of advanced revenue cycle analytics, AI-powered workflow and automation solutions. The strategic partnership leverages Accel-KKR’s extensive resources and strategic expertise to accelerate product innovation and expand VisiQuate’s team.

First Analysis, a leading venture capital investor, has made a new investment in Applied StemCell (ASC), a contract development and manufacturing organization (CDMO) specializing in tailored cell and gene therapy solutions. First Analysis co-invested in ASC alongside QHP Capital.

First Analysis, a leading venture capital investor, has made a new investment in Sware, which provides a complete software validation solution for innovative life sciences companies. The investment will be used to bolster research and development of Sware’s computer systems validation (CSV) platform, Res_Q, to further streamline processes with artificial intelligence (AI), and to expand the company’s sales team so it can bring the platform to more organizations struggling with validation debt.